| 2937.29.10 | 00 | Desonide; and Nandrolone phenproprionate | g | Free | | 15.4￠/kg + 49% |
| 2937.29.90 | 10 | Salts and esters of cortisone | g | | | |
| 2937.29.90 | 20 | Salts and esters of hydrocortisone | g | | | |
| 2937.29.90 | 30 | Salts and esters of prednisone | g | | | |
| 2937.29.90 | 40 | Salts and esters of prednisolone | g | | | |
| 2937.31.00 | 00 | Epinephrine | g | Free | | 15.4￠/kg + 49% |
| 2937.39.10 | 00 | Epinephrine hydrochloride | g | Free | | 15.4￠/kg + 49% |
| 2937.40.10 | 00 | l-Thyroxine (Levothyroxine), sodium | kg | Free | | 15.4￠/kg + 49% |
| 2940.00.20 | 00 | D-Arabinose | kg | Free | | 50% |
| 2941.10.30 | 00 | Carfecillin, sodium; Cloxacillin, sodium; Dicloxacillin, sodium; Flucloxacillin (Floxacillin); and Oxacillin, sodium | kg | Free | | 15.4￠/kg + 45% |
| 2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4￠/kg + 46.5% |
| 2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 46.5% |
| 3002.10.01 | 10 | Human blood plasma | kg | | | |
| 3002.10.01 | 30 | Human immune blood sera | kg | | | |
| 3002.20.00 | 00 | Vaccines for human medicine | kg | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3003.31.00 | 00 | Containing insulin | kg | Free | | 25% |
| 3004.10.10 | 10 | For veterinary use | kg | | | |
| 3004.10.50 | 10 | For veterinary use | kg | | | |
| 3004.20.00 | 10 | For veterinary use | kg | | | |
| 3004.31.00 | 00 | Containing insulin | kg | Free | | 25% |
| 3004.39.00 | 10 | For veterinary use | kg | | | |
| 3004.40.00 | 05 | For veterinary use | kg | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.50.30 | 00 | Vitamin E | kg | Free | | 15.4￠/kg + 63.5% |
